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027 probably reﬂ   ects the emergence 
of a new clone because MLVA clearly 
differentiates between clindamycin-
susceptible and -resistant isolates.
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Increasing 
Incidence of 
Clostridium 
difﬁ  cile–associated 
Disease, Singapore
To the Editor:  Clostridium dif-
ﬁ  cile–associated disease (CDAD) has 
increased in incidence across North 
America and Europe (1). Recent re-
ports document the emergence of an 
epidemic strain of C. difﬁ  cile, NAP1/
BI/027, associated with increased vir-
ulence (2,3). However, less informa-
tion is available regarding CDAD epi-
demiology in Asia. We examined the 
incidence of C. difﬁ  cile among hos-
pitalized patients in Singapore from 
2001 through 2006 and conducted a 
case–control study to evaluate risk 
factors for testing positive for C. dif-
ﬁ  cile toxin (CDT) in our population.
Tan Tock Seng Hospital (TTSH) 
is a 1,200-bed, acute-care general hos-
pital in Singapore that serves an urban 
population of 4 million. We calculated 
CDAD incidence using the number of 
patients testing positive for CDT per 
10,000 patient days from 2001 through 
2006. We used this calculation because 
CDT testing would have been ordered 
for clinical indications. CDT testing 
was performed by using the same 
ELISA (Premier Toxins A&B; Merid-
ian Bioscience, Inc., Cincinnati, OH, 
USA) throughout the entire period of 
investigation.
Case-patients and controls were 
selected from patients hospitalized at 
TTSH from January 1 through Decem-
ber 31, 2004. Microbiology laboratory 
records were used to deﬁ  ne 3 groups. 
Case-patients were deﬁ   ned as CDT-
positive inpatients (group 1). Two sets 
of negative controls were deﬁ  ned: the 
ﬁ   rst (group 2) consisted of patients 
who tested negative for CDT. How-
ever, because false-negatives could 
nullify differences between groups 1 
and 2, we deﬁ  ned a second set of neg-
ative controls (group 3) from among 
18,000 inpatients not tested for CDT. 
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Seventy patients were selected from 
each group by using a random num-
ber generator program. Forty-eight, 
61, and 56 records were retrieved for 
groups 1, 2, and 3, respectively. Stan-
dardized forms were used to extract 
data from hospital medical records. 
Demographic data and hospitalization 
details, including ward type (6-bed, 
4-bed, or single room), were collect-
ed. We examined antimicrobial drug 
use within 30 days of admission and 
within 30 days of CDT testing. We 
also evaluated the use of proton pump 
inhibitors (PPIs) and H2 blockers be-
cause these have been reported as risk 
factors (1,4–6). Outcomes ascertained 
included the time to discharge after 
CDT testing, and death within 30 days 
after CDT testing. The study was ap-
proved by the institutional ethics re-
view board.
Characteristics of case-patients 
and controls were compared by using 
the Wilcoxon rank sum test for con-
tinuous variables and the Fisher exact 
test for categorical variables. Variables 
signiﬁ  cantly associated with CDT in 
the univariate analysis were selected 
for inclusion in the multivariate re-
gression model. A 2-sided p value 
<0.05 was considered signiﬁ  cant for 
all comparisons.
CDAD incidence rose sharply 
from 1.49 cases per 10,000 patient-
days in 2001 to 6.64 cases per 10,000 
patient-days in 2006 (Figure). Dur-
ing the same period, the percentage 
of CDT-positive samples increased 
from 7% to 11%, while the number of 
samples tested increased from 906 to 
3,508.
Comparing group 1 (CDT posi-
tive) with group 2 (CDT negative), a 
CDT-positive result was more likely 
to occur in those with prolonged hos-
pital admissions (>14 days) than in 
those who had shorter hospital stays 
(<7 days; odds ratio [OR] 2.59, 95% 
conﬁ   dence interval [CI] 1.01–6.63). 
Of the 19 CDT-positive patients on 
PPIs and the 34 CDT-negative patients 
on PPIs, the median exposures were 
14 and 7 days, respectively (p = 0.01). 
In multivariate analysis, exposure to 
broad-spectrum antimicrobial drugs 
was a borderline signiﬁ  cant risk factor 
(adjusted OR 2.24, 95% CI 1.00–5.02, 
p = 0.05).
When group 1 (CDT positive) 
was compared with group 3 (not tested 
for CDT), quinolones (OR 6.67, 95% 
CI 1.85–24.03), anti-anaerobic anti-
microbial agents (OR 7.29, 95% CI 
2.39–22.26), and stay in a 6-bed ward 
(OR 3.15, 95% CI 1.01–9.82) were 
signiﬁ   cant risk factors in multivari-
ate analysis. Case-patients were more 
likely than controls to have a longer 
hospital stay after testing positive. The 
median hospital stay after CDT testing 
was 16 days for case-patients versus 
11 days for controls (p = 0.03).
This study documents a 4-fold 
rise in CDAD incidence among hos-
pitalized patients in Singapore from 
2001 through 2006. The current inci-
dence, 6.64 per 10,000 patient-days, 
is comparable to that reported by 
large hospitals in Canada (7), which 
indicates that CDAD has emerged as 
an important nosocomial infection in 
Singapore. This incidence rate, based 
on the number of patients (rather than 
the number of isolates) who had posi-
tive CDT test results, and the rise in 
sample positivity from 7% to 11% 
suggests that the higher rates are due 
to a true increased occurrence rather 
than merely more testing.
Possible factors driving the rise 
in CDAD include increased use of 
antimicrobial agents or changes in 
use patterns. The volume of quinolo-
nes and broad-spectrum antimicrobial 
drugs used at TTSH doubled between 
2002 and 2005, consistent with other 
studies implicating quinolones as a 
risk factor in CDAD (4).
Rising incidence or virulence 
could herald the geographic spread 
of new C. difﬁ  cile strains. Given the 
spread of NAP1/BI/027 strains in oth-
er parts of the world, this increased in-
cidence in Singapore should heighten 
vigilance for the introduction of out-
break strains into Asia.
The ﬁ  ndings from this study have 
implications for hospital management 
and infection control. Environmental 
contamination has been described as 
a mode of transmission (1). Potential 
crowding in 6-bed wards may increase 
spread of CDAD and may be particu-
larly relevant in busy healthcare facili-
Figure. Clostridium difﬁ  cile–associated disease incidence, Singapore, 2001–2006.  
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ties in Asia. CDAD is estimated to cost 
the healthcare system in the United 
States $3.2 billion annually (8). With 
longer hospitalization for persons af-
ter they test positive for CDT, as seen 
in our study, rising CDAD rates could 
increase hospital occupancy and result 
in excess healthcare expenditures.
CDAD in Asia is an emerging 
challenge that needs to be recognized. 
Its control will ultimately depend on 
priority being given to epidemiologic 
surveillance, infection control, and 
stewardship of antimicrobial agents.
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West Nile Virus 
in Golden Eagles, 
Spain, 2007 
To the Editor: Although West 
Nile virus (WNV) has not been isolat-
ed in Spain, several recent studies pro-
vide evidence for its circulation in this 
country (1–5). We report isolation of 
WNV in Spain from 2 golden eagles 
(Aquila chrysaetos). 
A captive-bred 2-year-old male 
golden eagle (GE-1) was released 
into the wild in central Spain. The 
bird’s location was monitored daily 
by telemetry, and it remained within 
a radius of 100 km from its original 
release point. On September 15, 2007 
(1 month after release), it was found 
moribund and was moved to a reha-
bilitation and captive breeding center 
for endangered raptors. Upon admis-
sion, the bird was in fair condition 
but debilitated and aggressive. It then 
became increasingly disorientated, 
showed a head tilt, and died 5 days 
after admission, despite intensive 
supportive care and treatment for sec-
ondary infections.
Eleven days after admission of 
GE-1, an adult male golden eagle 
(GE-2) and an adult female Bonelli’s 
eagle (Hieraaetus fasciatus [BE-1]) 
living in pairs (with a golden eagle 
and a Bonelli’s eagle, respectively) in 
enclosures were found disorientated, 
debilitated, and with impaired vision. 
Both birds where placed in isolation 
and received intensive supportive 
care; they slowly recovered. The re-
spective pair of each bird (GE-3 and 
BE-2, respectively) remained asymp-
tomatic. A magpie (MP-1) that had 
entered the golden eagle enclosure 5 
days before admission of GE-1 was 
also placed in isolation, but remained 
healthy. After necropsy of GE-1, 
tissue samples (brain, kidney, and 
spleen) from this bird and oropha-
ryngeal swabs from GE-2, BE-1, and 
MP-1 (obtained at day 11 after ad-
mission of GE-1) were subjected to 
virologic analysis.
Avian inﬂ   uenza and Newcastle 
disease were excluded by reverse 
transcription–PCR (RT-PCR) (6,7) of 
oropharyngeal and cloacal swabs from 
GE-1, GE-2, BE-1, and MP-1. Real-
time RT-PCR speciﬁ   c for WNV (8) 
was conducted with brain, kidney, and 
spleen tissue homogenates from GE-1 
and oropharyngeal swabs from GE-2, 
BE-1, and MP-1. All samples except 
that from MP-1 yielded speciﬁ  c WNV 
genome ampliﬁ  cation products, which 
were conﬁ  rmed  after  ampliﬁ  cation 
and sequencing by using a previously 
described method (9).
Serum samples from clinically 
affected eagles (GE-1, GE-2, and 
BE-1), the magpie (MP-1), and the 
healthy Bonelli’s eagle (BE-2) con-
tained WNV-neutralizing antibodies 
detected by a virus neutralization test 
performed as described (4,5). A serum 
sample from GE-3 (asymptomatic) 
remained negative up to 74 days af-
ter admission of GE-1. Speciﬁ  city of 
the neutralization test was assessed 